Aricept
Eisai Alzheimer’s drug to see China review
March 4, 2015Sales and Marketing Alzheimer's, Aricept, China, Eisai, donepezil hydrochloride
Alzheimer’s drug Aricept from Eisai has been accepted for review in China to treat patients with the most severe form …
Targacept admits failure in Alzheimer’s trial
July 15, 2014Research and Development, Sales and Marketing Alzheimer's, Aricept, Pfizer, TC-173, Targacept
Targacept is dropping a once promising Alzheimer’s drug from further clinical trials after it failed to beat Pfizer’s Aricept (donepezil) …
Keep Alzheimer’s patients on Aricept for longer, study says
March 8, 2012Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil
Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
Teva launches generic Aricept in the UK
February 16, 2012Manufacturing and Production, Sales and Marketing Alzheimer's, Aricept, NHS, Pfizer, Teva
Teva has launched its generic version of Alzheimer’s drug Aricept, as the drug loses its patent protection in the UK. …
Eisai confirms 20% cut in US workforce
March 8, 2011Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts
Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …
Eisai to cut 900 jobs ahead of Aricept patent loss
March 7, 2011Sales and Marketing Aricept, Eisai, donepezil, generics, job cuts
Eisai is to cut around 900 jobs in Europe, the US and Japan over the next five years as it …
Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs
November 17, 2010Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer
A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …
Battle for Alzheimer’s drugs finally over
October 8, 2010Sales and Marketing Alzheimer's, Aricept, NICE
NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …
NICE announces change of heart on Alzheimer’s
October 7, 2010Sales and Marketing Alzheimer's, Aricept, Ebixa, Exelon, NICE, Reminyl
NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …
Eisai opens $100m parenterals plant in North Carolina
May 24, 2010Manufacturing and Production, Research and Development Aricept, Eisai, eribulin, parenterals
Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …
